ProQR Therapeutics (PRQR) Return on Assets [ROA] (2014 - 2026)
ProQR Therapeutics (PRQR) posted Return on Assets [ROA] of -36.18% for the quarter ended Jun 30, 2026, down 8.75 percentage points from -27.43% a year earlier but up 6.46 percentage points from the prior quarter.
Powered by 
Analysis
ProQR Therapeutics (PRQR) Return on Assets [ROA] (2014 - 2026) Analysis & Trends
For the year ended Dec 31, 2025, ProQR Therapeutics' Return on Assets [ROA] came in at -30.83%, down 12.67 percentage points from the prior year.
- Annual Return on Assets [ROA] shows a five-year change of +12.73 percentage points (years ended Dec 2020 to Dec 2025).
- In prior years, ProQR Therapeutics' Return on Assets [ROA] was -18.16% in the year ended Dec 31, 2024 (+0.04 pp), -18.20% in the year ended Dec 31, 2023 (+13.38 pp), -31.58% in the year ended Dec 31, 2022 (+8.31 pp) and -39.89% in the year ended Dec 31, 2021 (+3.67 pp).
- Quarterly Return on Assets [ROA] has run from a low of -47.78% in the quarter ended Sep 30, 2022 to a high of -17.59% in the quarter ended Jun 30, 2024 over five years.
- On a year-over-year basis, Return on Assets [ROA] has declined in each of the last five quarters, with an average year-over-year change of -7.88 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was the quarter ended Dec 31, 2023, with a gain of 25.69 percentage points; the weakest was the quarter ended Mar 31, 2026, with a drop of 23.56 percentage points.
- According to Business Quant data, Return on Assets [ROA] for the three prior quarters was -42.64% (quarter ended Mar 31, 2026), -34.44% (quarter ended Dec 31, 2025) and -31.35% (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 19.00% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 7.32% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.87% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.36% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 9.80% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -7.67% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 2.00% |
| 10 | ProQR Therapeutics | 138.02 Mn | -322.63 Mn | - | -36.88% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -36.88% |
| Mar 31, 2026 | -42.86% |
| Dec 31, 2025 | -34.23% |
| Sep 30, 2025 | -30.73% |
| Jun 30, 2025 | -26.57% |
| Mar 31, 2025 | -19.09% |
| Dec 31, 2024 | -20.44% |
| Sep 30, 2024 | -21.18% |
| Jun 30, 2024 | -17.70% |
| Mar 31, 2024 | -20.12% |
| Dec 31, 2023 | -19.82% |
| Sep 30, 2023 | -24.23% |
| Jun 30, 2023 | -33.17% |
| Mar 31, 2023 | -34.35% |
| Dec 31, 2022 | -44.52% |
| Sep 30, 2022 | -48.64% |
| Jun 30, 2022 | -34.49% |
| Mar 31, 2022 | -32.67% |
| Dec 31, 2021 | -31.39% |
| Sep 30, 2021 | -32.27% |
API Access
ProQR Therapeutics Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=PRQR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "PRQR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=PRQR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();